iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Up 113.7% in February

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 70,842 shares, an increase of 113.7% from the February 12th total of 33,149 shares. Currently, 1.4% of the shares of the company are short sold. Based on an average daily volume of 27,581 shares, the days-to-cover ratio is presently 2.6 days. Based on an average daily volume of 27,581 shares, the days-to-cover ratio is presently 2.6 days. Currently, 1.4% of the shares of the company are short sold.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

Several hedge funds have recently added to or reduced their stakes in the business. Portland Global Advisors LLC grew its stake in shares of iShares Genomics Immunology and Healthcare ETF by 0.7% in the third quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock worth $2,432,000 after purchasing an additional 684 shares in the last quarter. Triumph Capital Management bought a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the third quarter valued at about $35,000. Ameriprise Financial Inc. lifted its holdings in iShares Genomics Immunology and Healthcare ETF by 8.4% in the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after purchasing an additional 5,540 shares during the period. Finally, Flow Traders U.S. LLC bought a new position in iShares Genomics Immunology and Healthcare ETF in the 2nd quarter valued at about $931,000.

iShares Genomics Immunology and Healthcare ETF Trading Down 0.4%

Shares of NYSEARCA:IDNA opened at $28.78 on Friday. The firm’s 50 day moving average is $29.16 and its two-hundred day moving average is $26.40. iShares Genomics Immunology and Healthcare ETF has a 52 week low of $17.26 and a 52 week high of $31.39. The firm has a market capitalization of $143.90 million, a P/E ratio of 14.76 and a beta of 1.07.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.